immunosorbent assay elisa human mip 1α ccl3 elisa kit  (Boster Bio)


Bioz Verified Symbol Boster Bio is a verified supplier
Bioz Manufacturer Symbol Boster Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Boster Bio immunosorbent assay elisa human mip 1α ccl3 elisa kit
    Expression of <t>CCL3,</t> CCR5, NF-κB, and TRAF6 in colorectal and CRC cells was measured by <t>ELISA</t> and Western blots. (a, a1; b, b1; c, c1) Representative immunoblots of CCR5, TRAF6, and NF-κB proteins in three human colon cancer cell lines (HCT116, SW620, HT29) and one normal colonic epithelial cell line (NCM460) (top panel), and the relative levels of these proteins (bottom panel). β-Actin was used as an internal control. (d) The expression of CCL3 protein was determined by ELISA. ns, *, **, and *** represent P > 0.05, P
    Immunosorbent Assay Elisa Human Mip 1α Ccl3 Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immunosorbent assay elisa human mip 1α ccl3 elisa kit/product/Boster Bio
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    immunosorbent assay elisa human mip 1α ccl3 elisa kit - by Bioz Stars, 2022-07
    93/100 stars

    Images

    1) Product Images from "Recombinant Bacteroides fragilis enterotoxin-1 (rBFT-1) promotes proliferation of colorectal cancer via CCL3-related molecular pathways"

    Article Title: Recombinant Bacteroides fragilis enterotoxin-1 (rBFT-1) promotes proliferation of colorectal cancer via CCL3-related molecular pathways

    Journal: Open Life Sciences

    doi: 10.1515/biol-2021-0043

    Expression of CCL3, CCR5, NF-κB, and TRAF6 in colorectal and CRC cells was measured by ELISA and Western blots. (a, a1; b, b1; c, c1) Representative immunoblots of CCR5, TRAF6, and NF-κB proteins in three human colon cancer cell lines (HCT116, SW620, HT29) and one normal colonic epithelial cell line (NCM460) (top panel), and the relative levels of these proteins (bottom panel). β-Actin was used as an internal control. (d) The expression of CCL3 protein was determined by ELISA. ns, *, **, and *** represent P > 0.05, P
    Figure Legend Snippet: Expression of CCL3, CCR5, NF-κB, and TRAF6 in colorectal and CRC cells was measured by ELISA and Western blots. (a, a1; b, b1; c, c1) Representative immunoblots of CCR5, TRAF6, and NF-κB proteins in three human colon cancer cell lines (HCT116, SW620, HT29) and one normal colonic epithelial cell line (NCM460) (top panel), and the relative levels of these proteins (bottom panel). β-Actin was used as an internal control. (d) The expression of CCL3 protein was determined by ELISA. ns, *, **, and *** represent P > 0.05, P

    Techniques Used: Expressing, Enzyme-linked Immunosorbent Assay, Western Blot

    Interference with rBFT-1 has effects on the expression of CCR5, TRAF6, NF-κb, and CCL3 in SW620 cells. (a–d) The relative expression of CCR5, NF-κb, and TRAF6. (e) The relative expression of CCL3 was determined by ELISA. ns, *, **, and *** represent P > 0.05, P
    Figure Legend Snippet: Interference with rBFT-1 has effects on the expression of CCR5, TRAF6, NF-κb, and CCL3 in SW620 cells. (a–d) The relative expression of CCR5, NF-κb, and TRAF6. (e) The relative expression of CCL3 was determined by ELISA. ns, *, **, and *** represent P > 0.05, P

    Techniques Used: Expressing, Enzyme-linked Immunosorbent Assay

    Interference with rBFT-1 has effects on the expression of CCR5, TRAF6, NF-κB, and CCL3 in NCM460 cells. (a–d) The relative expression of CCR5, NF-κb, and TRAF6. (e) The relative expression of CCL3 was determined by ELISA. ns, *, **, and *** represent P > 0.05, P
    Figure Legend Snippet: Interference with rBFT-1 has effects on the expression of CCR5, TRAF6, NF-κB, and CCL3 in NCM460 cells. (a–d) The relative expression of CCR5, NF-κb, and TRAF6. (e) The relative expression of CCL3 was determined by ELISA. ns, *, **, and *** represent P > 0.05, P

    Techniques Used: Expressing, Enzyme-linked Immunosorbent Assay

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    Boster Bio immunosorbent assay elisa human mip 1α ccl3 elisa kit
    Expression of <t>CCL3,</t> CCR5, NF-κB, and TRAF6 in colorectal and CRC cells was measured by <t>ELISA</t> and Western blots. (a, a1; b, b1; c, c1) Representative immunoblots of CCR5, TRAF6, and NF-κB proteins in three human colon cancer cell lines (HCT116, SW620, HT29) and one normal colonic epithelial cell line (NCM460) (top panel), and the relative levels of these proteins (bottom panel). β-Actin was used as an internal control. (d) The expression of CCL3 protein was determined by ELISA. ns, *, **, and *** represent P > 0.05, P
    Immunosorbent Assay Elisa Human Mip 1α Ccl3 Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immunosorbent assay elisa human mip 1α ccl3 elisa kit/product/Boster Bio
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    immunosorbent assay elisa human mip 1α ccl3 elisa kit - by Bioz Stars, 2022-07
    93/100 stars
      Buy from Supplier

    Image Search Results


    Expression of CCL3, CCR5, NF-κB, and TRAF6 in colorectal and CRC cells was measured by ELISA and Western blots. (a, a1; b, b1; c, c1) Representative immunoblots of CCR5, TRAF6, and NF-κB proteins in three human colon cancer cell lines (HCT116, SW620, HT29) and one normal colonic epithelial cell line (NCM460) (top panel), and the relative levels of these proteins (bottom panel). β-Actin was used as an internal control. (d) The expression of CCL3 protein was determined by ELISA. ns, *, **, and *** represent P > 0.05, P

    Journal: Open Life Sciences

    Article Title: Recombinant Bacteroides fragilis enterotoxin-1 (rBFT-1) promotes proliferation of colorectal cancer via CCL3-related molecular pathways

    doi: 10.1515/biol-2021-0043

    Figure Lengend Snippet: Expression of CCL3, CCR5, NF-κB, and TRAF6 in colorectal and CRC cells was measured by ELISA and Western blots. (a, a1; b, b1; c, c1) Representative immunoblots of CCR5, TRAF6, and NF-κB proteins in three human colon cancer cell lines (HCT116, SW620, HT29) and one normal colonic epithelial cell line (NCM460) (top panel), and the relative levels of these proteins (bottom panel). β-Actin was used as an internal control. (d) The expression of CCL3 protein was determined by ELISA. ns, *, **, and *** represent P > 0.05, P

    Article Snippet: 2.4 Enzyme-linked immunosorbent assay (ELISA) Human MIP-1α/CCL3 ELISA Kit (BOSTER technology, China) was used to detect the impact of rBFT1 on the expression of CCL3 that SW620 and NCM460 cells secrete in the medium.

    Techniques: Expressing, Enzyme-linked Immunosorbent Assay, Western Blot

    Interference with rBFT-1 has effects on the expression of CCR5, TRAF6, NF-κb, and CCL3 in SW620 cells. (a–d) The relative expression of CCR5, NF-κb, and TRAF6. (e) The relative expression of CCL3 was determined by ELISA. ns, *, **, and *** represent P > 0.05, P

    Journal: Open Life Sciences

    Article Title: Recombinant Bacteroides fragilis enterotoxin-1 (rBFT-1) promotes proliferation of colorectal cancer via CCL3-related molecular pathways

    doi: 10.1515/biol-2021-0043

    Figure Lengend Snippet: Interference with rBFT-1 has effects on the expression of CCR5, TRAF6, NF-κb, and CCL3 in SW620 cells. (a–d) The relative expression of CCR5, NF-κb, and TRAF6. (e) The relative expression of CCL3 was determined by ELISA. ns, *, **, and *** represent P > 0.05, P

    Article Snippet: 2.4 Enzyme-linked immunosorbent assay (ELISA) Human MIP-1α/CCL3 ELISA Kit (BOSTER technology, China) was used to detect the impact of rBFT1 on the expression of CCL3 that SW620 and NCM460 cells secrete in the medium.

    Techniques: Expressing, Enzyme-linked Immunosorbent Assay

    Interference with rBFT-1 has effects on the expression of CCR5, TRAF6, NF-κB, and CCL3 in NCM460 cells. (a–d) The relative expression of CCR5, NF-κb, and TRAF6. (e) The relative expression of CCL3 was determined by ELISA. ns, *, **, and *** represent P > 0.05, P

    Journal: Open Life Sciences

    Article Title: Recombinant Bacteroides fragilis enterotoxin-1 (rBFT-1) promotes proliferation of colorectal cancer via CCL3-related molecular pathways

    doi: 10.1515/biol-2021-0043

    Figure Lengend Snippet: Interference with rBFT-1 has effects on the expression of CCR5, TRAF6, NF-κB, and CCL3 in NCM460 cells. (a–d) The relative expression of CCR5, NF-κb, and TRAF6. (e) The relative expression of CCL3 was determined by ELISA. ns, *, **, and *** represent P > 0.05, P

    Article Snippet: 2.4 Enzyme-linked immunosorbent assay (ELISA) Human MIP-1α/CCL3 ELISA Kit (BOSTER technology, China) was used to detect the impact of rBFT1 on the expression of CCL3 that SW620 and NCM460 cells secrete in the medium.

    Techniques: Expressing, Enzyme-linked Immunosorbent Assay